Table 1.
The clinic- pathological features of patients with pituitary adenoma
| Parameter | Groups | Pituitary adenoma (n = 71) |
Non-Functional pituitary adenoma (n = 30) |
Functional pituitary adenoma (n = 41) |
Acromegaly (n = 20) |
Cushing (n = 13) |
Prolactinoma (n = 8) |
|---|---|---|---|---|---|---|---|
| Age (Years) | 20–40 | 34(47.88%) | 13(43.33%) | 21(51.21%) | 10(50%) | 7(53.84%) | 4(50%) |
| 40–60 | 22(30.98%) | 9(30%) | 13(31.70%) | 6(30%) | 5(38.46%) | 2(25%) | |
| 60≤ | 15(21.12%) | 8(26.66%) | 7(17.07%) | 4(20%) | 1(7.69%) | 2(25%) | |
| Gender | Female | 34(47.88%) | 12(40%) | 22(53.65%) | 11(55%) | 8(61.53%) | 3(37.5%) |
| Male | 37(52.11%) | 18(60%) | 19(46.34%) | 9(45%) | 5(38.46%) | 5(62.5%) | |
| Tumor invasiveness | Invasive | 33(46.47%) | 13(43.33%) | 20(48.78%) | 10(50%) | 4(30.76%) | 6(75%) |
| Non- Invasive | 38(53.52%) | 17(56.66%) | 21(51.21%) | 10(50%) | 9(69.23%) | 2(25%) | |
| Tumor size | Micro-Adenoma | 16(22.53%) | 0 | 16(39.02%) | 8(40%) | 8(61.53%) | 0 |
| Macro-Adenoma | 55(77.46%) | 30(100%) | 25(60.97%) | 12(60%) | 5(38.46%) | 8(100%) |